Skip to content
Monday, November 9, 2026
Classic Studio Factory

Zimbabwe Rejects ‘Unbalanced’ US Healthcare Assistance Deal Over Data Concerns

Medical aid illustration
The offered US financial assistance was aimed at initiatives for treating and preventing HIV/Aids, tuberculosis, and malaria.

The nation of Zimbabwe has declined a significant US healthcare agreement valued at $367m (272 million pounds) spanning five years over Washington's demand for sensitive biological samples.

This move came to light after a internal memorandum from December was leaked, which showed Head of State Emmerson Mnangagwa felt the deal was "skewed".

An official spokesman later explained that the US was requesting health data for scientific study and profit while was unwilling to share the benefits from future medical innovations.

"We will now turn to the challenging and unfortunate task of scaling back our health aid in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.

Her embassy indicated the United States had donated over $1.9bn as health assistance to Zimbabwe over the last two decades.

A doctors' association in Zimbabwe has called for more talks to secure a deal agreeable to all parties so the country's vital HIV programme can continue.

Wider Background

This rejection comes after a similar situation in neighbouring Kenya, where a high court suspended a similar health funding agreement following legal challenges were raised about the security of citizens' medical information.

After returning to office last year, US President Donald Trump has reduced overseas assistance and closed the US Agency for International Development (USAID).

The agency had managed aid for the American government, but Trump argued its expenditure was "wasteful" and his administration was pursuing direct bilateral deals to boost openness and responsibility.

According to statements, 16 nations in Africa have so far agreed to similar health pacts, constituting more than $18.3bn in new funding.

Specifics of the Rejected Deal

The money for Zimbabwe was intended to supported "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".

"We believe this collaboration might have yielded immense advantages for Zimbabwean communities, particularly the 1.2 million men, women and children presently receiving HIV treatment through American-funded initiatives," the Ambassador added.

However, official spokesman Nick Mangwana maintained the arrangement was "unequal".

"The proposal required Zimbabwe to provide its biological resources and data over an extended period, with no corresponding assurance of benefiting from any medical innovations – like new medicines or tests – that could be developed from that provided information," he stated.

"Effectively, our country would supply the raw materials for scientific discovery without any certainty that the final treatments would be accessible to our people if a future health crisis emerge."

Sovereignty and International Frameworks

Mangwana further said that the American exit from the global health body and its push of bilateral health agreements were undermining frameworks previously established through the global organization.

Mangwana gave as an example its Pathogen Access and Benefit Sharing scheme created to manage potential global health emergencies.

"This system is intended to guarantee that when a nation provides its information, the benefits – such as medicines and cures – are distributed fairly, not commercialised exclusively by those with the resources to develop them."

The government's concerns regarding the US deal "must not be interpreted as opposition to America," Mangwana stressed.

"We welcome continued discussions with our US partners on how subsequent collaboration might be arranged in a way that respects the sovereignty and interests of each country."

Health Experts Response

Medical experts said it understood the official position, but urged that negotiations should continue considering much of the country's HIV programmes were funded by external financing.

"In cases where specific concerns exist, such as those relating to data governance or implementation frameworks, these can frequently be resolved through technical clarification and mutually agreed protections," it commented.

The situation highlights the continuing debate between accepting much-needed international aid and safeguarding local interests in an ever more interconnected world.

By

Samantha Smith

Lena is a freelance designer and blogger who loves exploring the intersection of art and technology.

Classic Studio Factory

Type to search articles.